Differential Effects of Ang-2/VEGF-A Inhibiting Antibodies in Combination with Radio- or Chemotherapy in Glioma

Antiangiogenic strategies have not shown striking antitumor activities in the majority of glioma patients so far. It is unclear which antiangiogenic combination regimen with standard therapy is most effective. Therefore, we compared anti-VEGF-A, anti-Ang2, and bispecific anti-Ang-2/VEGF-A antibody t...

Descripción completa

Detalles Bibliográficos
Autores principales: Solecki, Gergely, Osswald, Matthias, Weber, Daniel, Glock, Malte, Ratliff, Miriam, Müller, Hans-Joachim, Krieter, Oliver, Kienast, Yvonne, Wick, Wolfgang, Winkler, Frank
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468722/
https://www.ncbi.nlm.nih.gov/pubmed/30845704
http://dx.doi.org/10.3390/cancers11030314

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6468722/
https://www.ncbi.nlm.nih.gov/pubmed/30845704
http://dx.doi.org/10.3390/cancers11030314

Ejemplares similares